ESR1 and breast carcinoma: In particular, it has been demonstrated that miR-29a is upregulated in ER- breast cancer, as compared with ER+ breast cancer tissues and adjacent non-tumor tissues, and this correlates with tumor metastasis and overall short survival [228].